Scientia Ventures
Venture capitalNew York · Series A–Series B · 13 people tracked
Also known as VANTAGE CONSULTING GROUP INC
Find your way into Scientia Ventures
459 people in our graph share verified history with the Scientia Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Scientia Ventures targets novel and unique innovations with breakthrough potential, concentrating on the science and technology advances required to achieve radical change. As a global firm, it aims to pair the expertise and network of its team with visionary entrepreneurs, using its experience, deep network, and flexible approach as a proprietary edge. The team works to identify optimal strategic approaches and solutions for its portfolio companies, and its investors and general partners take a long-term view of venture success.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 23 of 27 portfolio companiesBiotech ×14Healthtech ×13Medical Devices ×6SaaS ×6Deep Tech ×5Fintech ×5AI & Machine Learning ×3Digital Health ×3
HQs:United States×14China×2
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×52 founders×53 founders×1
Investments · 27 tracked
founders shown can be your intro pathBy year:2020 · 12018 · 12016 · 12015 · 12014 · 37 dated
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology.
BiotechHealthtechMedical Devices
Ameet Mallik(Chief Executive Officer)inJose Carmona(Chief Financial Officer)Mohamed Zaki(Chief Medical Officer)inKristen Harrington-Smith(Chief Commercial Officer)inDavid Ege(Chief Technical Officer)inPeter Graham(Chief Legal Officer)in
Co-investorsETCapitalHEALTHCARE ROYALTY PARTNERS
Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk.
BiotechFintechNew York, US
Pablo Legorreta(Chairman and CEO)in
Co-investorsPaladin Capital Group
Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders.
BiotechHealthtechMedical Devices
Enda Kenny(CEO)inLynn Sullivan(Chief Business Officer)in
Co-investorsRosetta Capital Ltd.
Cibus develops crops using a proprietary gene-editing technology that reproduces nature's own genetic blueprints to add specific traits, such as resistance to heat, pests, fungus, and weeds.
AgTechBiotechClimate TechSan Diego, US
Peter Beetham(Chief Executive Officer)inRory Riggs(Chairman of the Board)Keith Walker, Ph.D.(President)LaDon Johnson(Executive Officer)in
BoardAlain Pompidou(Director)
Board seatMark FinnRory Riggs· per SEC Form D
eReceivables is a healthcare revenue recovery firm that specializes in identifying and resolving underpaid, denied, and overlooked insurance claims for hospitals and healthcare systems.
Enterprise SoftwareFintechHealthtechSaaSHollywood, US
William Whitaker(Chief Operating Officer)Gil Perry(Executive Officer)Steven Griffin(President)
BoardBarbara Rohan(Director)
Board seatRory RiggsJonathan Finn· per SEC Form D
1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Co-investorsY CombinatorFoundersX VenturesPlayground Global
ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers.
Data & InfrastructureHealthtechInsurTechSaaSBrookfield, US
Lea DeVillers(Executive Officer)inDavid A. Sockel(Executive Officer)inJeffrey A. Surges(Executive Officer, Director)Mark E. Granville(Executive Officer)James P. Purko(Executive Officer)inRobert Douglas Schneider(Executive Officer)
Co-investorsAtlanta Technology AngelsChrysalis Ventures
Cristcot is a pharmaceutical development and medical device company focused on drug formulations, device engineering, and clinical development.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Jennifer J. Davagian(Founder/Chief Executive Officer)inMark C. Ensign(Founder/Chief Operating Officer/Chief Scientific Officer)in
Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions.
BiotechHealthtechSan Francisco, US
Thomas B. Neff(Executive Officer, Director)Frank H. Valone(Executive Officer)inK. Peony Yu(Executive Officer)inPat Cotroneo(Executive Officer)in
BoardRory B. Riggs(Director)Kalevi Kurkijarvi(Director)
Co-investorsAvalon BioVenturesRidgeback CapitalMaverick Ventures
Mission Bay Capital is an early-stage investment firm dedicated to funding and supporting entrepreneur-scientists building companies to address chronic diseases and environmental challenges.
BiotechDeep TechFintechImpact & Social GoodSan Francisco, US
BoardDouglas Crawford(Managing General Partner)Peter D. Parker(Venture Partner)
Co-investorsAndreessen HorowitzavraBONDBritish International InvestmentCapitalGDurable Capital Partners+10 more
BioPharma Credit is an investment fund that generates returns through debt financing secured by royalties and cash flows from life sciences product sales.
Fintech
X-vax Legend sells "Nagapetir" branded decorative stickers with various designs for use on motorcycles, cars, laptops, helmets, and community or brand promotion.
E-commerce
Co-investorsAdjuvant Capital
Humanity offers an enterprise employee wellness platform that uses biological age monitoring to help teams improve health and productivity.
Digital HealthHealthtechHR TechLongevityWellness & Fitness
Peter Ward(Founder)in
Co-investorsOne Way VenturesAndreessen HorowitzDeerfield Management CompanyJump CryptoJumpstart NovaPantera Capital+1 more
Intelinair provides aerial imagery and agronomic analytics through its AGMRI platform, delivering in-season alerts and postseason reporting on crop health, weeds, nitrogen deficiency, stand assessment, and yield loss.
AgTechAI & Machine LearningSaaSSan Jose, US
Naira Hovakimyan(Chief Scientific Officer and Secretary)inAl Eisaian(Founder)in
Co-investorsGranatus VenturesHyde Park Venture Partners
A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms.
BiotechDigital HealthHealthtechMedical Devices
Paul Greengard
MarketMuse provides AI-powered content strategy and research tools for SEO and content teams, enabling them to analyze content inventories at scale, generate optimized briefs, and plan content strategy around user intent and search requirements.
AI & Machine LearningMarketing TechSaaS
Aki BaloghinJeff Coyle(Co-Founder & Chief Revenue Officer)in
Co-investorsAlpine MeridianColle Capital PartnersLaunchCapitalLunaCap VenturesRevUp CapitalRiverside Acceleration Capital+4 more
首信易支付 (PayEase) provides cross-border card acquiring services supporting international credit cards such as Visa, Mastercard, American Express, JCB, Discover, and Diners Club.
E-commerceFintechSaaS
Pharmaron is a contract research and manufacturing organization providing drug development and manufacturing services to pharmaceutical and biotech companies.
BiotechDeep TechHealthtechMedical DevicesBeijing, CN
Boliang Lou(Chairman & CEO)in
Co-investorsAisling CapitalDCM VenturesDCMLegend Capital
Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women.
BiotechFemTechHealthtechRaleigh, US
Robert S. Whitehead(Director, Executive Director)Cindy Eckert(Founder)Cynthia Whitehead(Chief Commercial Officer)Anne Tomalin(Vice President, Global Regulatory Affairs)Matthew Petzold(Chief Financial Officer and Treasurer)Douglas Eckert(Director, Secretary)
Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally.
BiotechDeep TechHealthtechMedical Devices
Petter Björquist(Chief Executive Officer)inRaimund Strehl(Chief Technology Officer)inEdvard Nordfors(Chief Financial Officer)in
Co-investorsCapital Cell
WHT provides a technology platform designed for private and protected intentional communities that enhances member connections and care support while maintaining human-centered communication.
Digital HealthHealthtechSaaSCharlottesville, US
Rebecca Dillingham(Co-founder)Karen Ingersoll(Co-founder)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GenenewsAuven TherapeuticsEnterinTransparency Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
2 IPOsADC Therapeutics SANYSE: ADCTRoyalty PharmaNASDAQ: RPRX
Portfolio news
latest coverage across their companiesFund I · techmoran.com · Sep 13, 2026
Royalty Pharma · investing.com · Sep 8, 2026
ADC Therapeutics SA · stocktitan.net · Aug 14, 2026
Cibus · stocktitan.net · Jan 28, 2026
Pharmaron · prnewswire.com · Jan 27, 2026
IntelinAir | AGMRI · intelinair.com · Dec 3, 2025
1910 · tobaccoreporter.com · Sep 10, 2025
Frequently asked questions
- How many investments has Scientia Ventures made?
- Scientia Ventures has 27 tracked investments, 2 of which have exited.
- What stage does Scientia Ventures invest at?
- Scientia Ventures invests at the Series A, Series B stages.
- What sectors does Scientia Ventures focus on?
- Scientia Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Scientia Ventures located?
- Scientia Ventures is headquartered in New York, US.
- Who does Scientia Ventures co-invest with?
- Scientia Ventures most often shares deals with DCM Ventures, Granatus Ventures, One Way Ventures, among 14 tracked co-investors.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.